Sleep outcomes following eszopiclone discontinuation in patients with primary insomnia and insomnia co-existing with major depressive disorder or generalized anxiety disorder

被引：0
|
作者：
Krystal, A.
Fava, M.
Pollack, M.
Rubens, R.
Schaefer, K.
Amato, D.
Roth, T.
机构：
[1] Duke Univ, Durham, NC 27706 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Sepracor Inc, Marlborough, MA USA
来源：
SLEEP | 2007年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
720
引用
收藏
页码：A245 / A245
页数：1
相关论文
共 50 条
  • [1] Sleep outcomes following eszopiclone discontinuation in patients with primary insomnia co-existing with major depressive disorder or generalized anxiety disorder
    Krystal, Andrew
    Fava, Maurizio
    Pollack, Mark
    Rubens, Robert
    Schaefer, Kendyl
    Amato, David
    Roth, Thomas
    [J]. BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 84S - 84S
  • [2] Differential sleep effects of eszopiclone treatment and discontinuation in patients with primary insomnia and insomnia co-existing with major depressive disorder or generalized anxiety disorder
    Krystal, A.
    Schaefer, K.
    Rockett, C.
    Fava, M.
    Amato, D.
    Roth, T.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 306 - 306
  • [3] Differential sleep effects of eszopiclone treatment and discontinuation in patients with primary insomnia and insomnia co-existing with major depressive disorder (MDD) or generalized anxiety disorder (GAD)
    Fava, M.
    Schaefer, K.
    Rockett, C. B.
    Amato, D.
    Roth, T.
    [J]. JOURNAL OF SLEEP RESEARCH, 2008, 17 : 192 - 192
  • [4] Insomnia severity in patients with primary insomnia and insomnia co-morbid with major depressive disorder or generalized anxiety disorder
    Roth, Thomas
    Wilson, Phebe
    Schaefer, Kendyl
    Pfleeger, Kimberly
    Rubens, Robert
    Fava, Maurizio
    Pollack, Mark
    [J]. BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 84S - 85S
  • [5] Eszopiclone co-administered with fluoxetine for insomnia co-existing with major depressive disorder (MDD): Analysis by severity of insomnia
    McCall, V
    Krystal, A.
    Fava, M.
    Rubens, R.
    Schaefer, K.
    Huang, H.
    Amato, D.
    Roth, T.
    [J]. SLEEP, 2006, 29 : A249 - A249
  • [6] Evaluation of the Hamilton depression scale following eszopiclone treatment for insomnia in patients with insomnia co-morbid with major depressive disorder or generalized anxiety disorder
    Fava, M.
    Pollack, M.
    Rubens, R.
    Amato, D.
    Kostal, A.
    Hayduk, R.
    McCall, W.
    [J]. SLEEP, 2007, 30 : A329 - A330
  • [7] Evaluation of the Hamilton depression scale following eszopiclone treatment for insomnia in patients with insomnia co-morbid with major depressive disorder or generalized anxiety disorder
    Fava, Maurizio
    Pollack, Mark
    Rubens, Robert
    Amato, David
    Krystal, Andrew
    Hayduk, Roza
    McCall, W. Vaughn
    [J]. BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 84S - 84S
  • [8] Relative effect sizes of eszopiclone treatment for insomnia in patients with primary insomnia and insomnia co-morbid with major depressive disorder, generalized anxiety disorder, perimenopausal transition or rheumatoid arthritis
    Schaefer, K.
    McCall, W.
    Krystal, A.
    Rubens, R.
    Wilson, P.
    Pfleeger, K.
    Roth, T.
    [J]. SLEEP, 2007, 30 : A243 - A244
  • [9] Eszopiclone co-administered with fluoxetine for insomnia co-existing with major depressive disorder (MDD): A subgroup analysis
    Fava, M.
    McCall, W. V.
    Wessel, T.
    Amato, D.
    Paska, W.
    Montgomery, S.
    Roth, T.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 306 - 306
  • [10] Eszopiclone co-administered with fluoxetine for insomnia co-existing with major depressive disorder (MDD): a subgroup analysis
    Roth, T.
    Mccall, W.
    Wessel, T.
    Amato, D.
    Paska, W.
    Fava, M.
    [J]. JOURNAL OF SLEEP RESEARCH, 2008, 17 : 191 - 192
12345